| Product Code: ETC5311309 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Portugal`s import shipments for pulmonary/respiratory drug delivery devices in 2024 were primarily sourced from key European countries including Germany, Spain, Belgium, Metropolitan France, and the Netherlands. The market concentration, as measured by the HHI, remained low in 2024, indicating a diverse import market. The compound annual growth rate (CAGR) from 2020 to 2024 was at a steady 2.5%, with a slight uptick in the growth rate from 2023 to 2024 at 2.21%, reflecting a stable and gradually expanding market for pulmonary/respiratory drug delivery imports in Portugal.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Pulmonary/ Respiratory Drug Delivery Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Pulmonary/ Respiratory Drug Delivery Market - Industry Life Cycle |
3.4 Portugal Pulmonary/ Respiratory Drug Delivery Market - Porter's Five Forces |
3.5 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Formulations, 2021 & 2031F |
3.6 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Canister Type, 2021 & 2031F |
3.7 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.8 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Portugal Pulmonary/ Respiratory Drug Delivery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in Portugal |
4.2.2 Growing awareness about pulmonary drug delivery technologies |
4.2.3 Technological advancements in respiratory drug delivery devices |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of respiratory drug delivery products |
4.3.2 Limited reimbursement policies for respiratory medications in Portugal |
4.3.3 High cost associated with development and manufacturing of pulmonary drug delivery devices |
5 Portugal Pulmonary/ Respiratory Drug Delivery Market Trends |
6 Portugal Pulmonary/ Respiratory Drug Delivery Market Segmentations |
6.1 Portugal Pulmonary/ Respiratory Drug Delivery Market, By Formulations |
6.1.1 Overview and Analysis |
6.1.2 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Device Type, 2021-2031F |
6.2 Portugal Pulmonary/ Respiratory Drug Delivery Market, By Canister Type |
6.2.1 Overview and Analysis |
6.2.2 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Plain Canister, 2021-2031F |
6.2.3 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Coated Canister, 2021-2031F |
6.3 Portugal Pulmonary/ Respiratory Drug Delivery Market, By Applications |
6.3.1 Overview and Analysis |
6.3.2 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Asthma, 2021-2031F |
6.3.3 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By COPD, 2021-2031F |
6.3.4 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Cystic Fibrosis, 2021-2031F |
6.4 Portugal Pulmonary/ Respiratory Drug Delivery Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Hospitals & Clinics, 2021-2031F |
6.4.3 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenues & Volume, By Homecare settings, 2021-2031F |
7 Portugal Pulmonary/ Respiratory Drug Delivery Market Import-Export Trade Statistics |
7.1 Portugal Pulmonary/ Respiratory Drug Delivery Market Export to Major Countries |
7.2 Portugal Pulmonary/ Respiratory Drug Delivery Market Imports from Major Countries |
8 Portugal Pulmonary/ Respiratory Drug Delivery Market Key Performance Indicators |
8.1 Patient adherence rate to pulmonary drug delivery treatments |
8.2 Number of clinical trials conducted for respiratory drug delivery products |
8.3 Adoption rate of innovative pulmonary drug delivery technologies |
8.4 Number of partnerships and collaborations in the Portugal respiratory drug delivery market |
8.5 Rate of hospital admissions due to respiratory diseases in Portugal |
9 Portugal Pulmonary/ Respiratory Drug Delivery Market - Opportunity Assessment |
9.1 Portugal Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Formulations, 2021 & 2031F |
9.2 Portugal Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Canister Type, 2021 & 2031F |
9.3 Portugal Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.4 Portugal Pulmonary/ Respiratory Drug Delivery Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Portugal Pulmonary/ Respiratory Drug Delivery Market - Competitive Landscape |
10.1 Portugal Pulmonary/ Respiratory Drug Delivery Market Revenue Share, By Companies, 2024 |
10.2 Portugal Pulmonary/ Respiratory Drug Delivery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |